Literature DB >> 25839741

Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy.

Thomas Stehlé1, Vincent Audard2, Pierre Ronco3, Hanna Debiec3.   

Abstract

Of the glomerulonephritis associated with sarcoidosis, membranous nephropathy (MN) is the most prevalent. Coincidence or a causal relationship between these two diseases is unclear. Here, we present for the first time a high prevalence of PLA2R-related MN among patients with MN associated with active sarcoidosis. Our results suggest some causal link between sarcoidosis and PLA2R-related MN. Detection of anti-PLA2R antibodies in serum or PLA2R antigen in biopsy should not be taken as evidence against a secondary cause, particularly sarcoidosis. This important observation can affect treatment decision in these patients.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  membranous nephropathy; phospholipase A2 receptor; sarcoidosis

Mesh:

Substances:

Year:  2015        PMID: 25839741     DOI: 10.1093/ndt/gfv080

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

1.  Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.

Authors:  A Radice; F Pieruzzi; B Trezzi; G Ghiggeri; P Napodano; M D'Amico; T Stellato; R Brugnano; F Ravera; D Rolla; G Pesce; M E Giovenzana; F Londrino; V Cantaluppi; F Pregnolato; A Volpi; G Rombolà; G Moroni; G Ortisi; Renato A Sinico
Journal:  J Nephrol       Date:  2017-10-28       Impact factor: 3.902

Review 2.  Treatment of primary membranous nephropathy: where are we now?

Authors:  Andrea Angioi; Nicola Lepori; Ana Coloma López; Sanjeev Sethi; Fernando C Fervenza; Antonello Pani
Journal:  J Nephrol       Date:  2017-09-05       Impact factor: 3.902

Review 3.  A Proposal for a Serology-Based Approach to Membranous Nephropathy.

Authors:  An S De Vriese; Richard J Glassock; Karl A Nath; Sanjeev Sethi; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 10.121

Review 4.  Membranous nephropathy-one morphologic pattern with different diseases.

Authors:  Elion Hoxha; Franziska von Haxthausen; Thorsten Wiech; Rolf A K Stahl
Journal:  Pflugers Arch       Date:  2017-05-29       Impact factor: 3.657

Review 5.  Renal sarcoidosis.

Authors:  Marta Calatroni; Gabriella Moroni; Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2022-06-27       Impact factor: 4.393

6.  A case of systemic sarcoidosis with mesangial proliferative glomerulonephritis showing predominant deposition of IgG in the mesangial region.

Authors:  Kimio Watanabe; Sho Fukui; Kasumi Konishi; Yugo Ito; Takuya Fujimaru; Masahiko Nagahama; Fumika Taki; Koyu Suzuki; Masaaki Nakayama
Journal:  CEN Case Rep       Date:  2021-11-09

Review 7.  Primary membranous nephropathy: an endless story.

Authors:  Ponticelli Claudio
Journal:  J Nephrol       Date:  2022-10-17       Impact factor: 4.393

Review 8.  Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms.

Authors:  Corrado Murtas; Gian Marco Ghiggeri
Journal:  J Nephrol       Date:  2016-01-25       Impact factor: 3.902

Review 9.  Genetics of membranous nephropathy.

Authors:  Sanjana Gupta; Anna Köttgen; Elion Hoxha; Paul Brenchley; Detlef Bockenhauer; Horia C Stanescu; Robert Kleta
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

Review 10.  Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy.

Authors:  Bogdan Obrisca; Gener Ismail; Roxana Jurubita; Catalin Baston; Andreea Andronesi; Gabriel Mircescu
Journal:  Biomed Res Int       Date:  2015-10-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.